174 related articles for article (PubMed ID: 25171842)
1. Preparation and testing of a Vi conjugate vaccine using pneumococcal surface protein A (PspA) from Streptococcus pneumoniae as the carrier protein.
Kothari N; Genschmer KR; Kothari S; Kim JA; Briles DE; Rhee DK; Carbis R
Vaccine; 2014 Sep; 32(43):5755-60. PubMed ID: 25171842
[TBL] [Abstract][Full Text] [Related]
2. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
[TBL] [Abstract][Full Text] [Related]
3. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
Lin H; Peng Y; Lin Z; Zhang S; Guo Y
Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
[TBL] [Abstract][Full Text] [Related]
4. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
5. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune response of a pneumococcal conjugate vaccine: capsular polysaccharide serotype 14-Lysine modified PspA.
Santamaria R; Goulart C; Perciani CT; Barazzone GC; Carvalho R; Gonçalves VM; Leite LC; Tanizaki MM
Vaccine; 2011 Nov; 29(47):8689-95. PubMed ID: 21906649
[TBL] [Abstract][Full Text] [Related]
7. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
8. A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.
Lu YJ; Zhang F; Sayeed S; Thompson CM; Szu S; Anderson PW; Malley R
Vaccine; 2012 May; 30(23):3405-12. PubMed ID: 22465750
[TBL] [Abstract][Full Text] [Related]
9. Protection induced by pneumococcal surface protein A (PspA) is enhanced by conjugation to a Streptococcus pneumoniae capsular polysaccharide.
Csordas FC; Perciani CT; Darrieux M; Gonçalves VM; Cabrera-Crespo J; Takagi M; Sbrogio-Almeida ME; Leite LC; Tanizaki MM
Vaccine; 2008 Jun; 26(23):2925-9. PubMed ID: 18440673
[TBL] [Abstract][Full Text] [Related]
10. Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice.
Piao Z; Akeda Y; Takeuchi D; Ishii KJ; Ubukata K; Briles DE; Tomono K; Oishi K
Vaccine; 2014 Sep; 32(43):5607-13. PubMed ID: 25132335
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
12. Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine.
An SJ; Yoon YK; Kothari S; Kim DR; Kim JA; Kothari N; Lee E; Park TH; Carbis R
Vaccine; 2012 Feb; 30(6):1023-8. PubMed ID: 22192846
[TBL] [Abstract][Full Text] [Related]
13. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
Yu J; Chen X; Li B; Gu T; Meng X; Kong W; Wu Y
Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model.
Verhoeven D; Xu Q; Pichichero ME
Vaccine; 2014 May; 32(26):3205-10. PubMed ID: 24731814
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic protein contaminants in pneumococcal vaccines.
Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
[TBL] [Abstract][Full Text] [Related]
16. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.
Frey SE; Lottenbach KR; Hill H; Blevins TP; Yu Y; Zhang Y; Brenneman KE; Kelly-Aehle SM; McDonald C; Jansen A; Curtiss R
Vaccine; 2013 Oct; 31(42):4874-80. PubMed ID: 23916987
[TBL] [Abstract][Full Text] [Related]
17. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
[TBL] [Abstract][Full Text] [Related]
18. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
Briles DE; Hollingshead SK; King J; Swift A; Braun PA; Park MK; Ferguson LM; Nahm MH; Nabors GS
J Infect Dis; 2000 Dec; 182(6):1694-701. PubMed ID: 11069242
[TBL] [Abstract][Full Text] [Related]
19. Rational selection of broadly cross-reactive family 2 PspA molecules for inclusion in chimeric pneumococcal vaccines.
Converso TR; Goulart C; Rodriguez D; Darrieux M; Leite LCC
Microb Pathog; 2017 Aug; 109():233-238. PubMed ID: 28602840
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Immunogenicity and Protection of Two Pneumococcal Protein Vaccines Based on PsaA and PspA.
Yu J; Li B; Chen X; Lu J; Wang D; Gu T; Kong W; Wu Y
Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29610257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
